// App-Quantinova.ai

e17036 : Novel formulation of abiraterone acetate with significantly higher bioavailability and eliminated food effect might allow higher abiraterone exposure and better patient outcome.

Researchers

Presenter

  • Hristos Glavinas

Principal Investigators

  • Tamas Solymosi

  • Zsolt Otvos

  • Reka Angi

  • Betti Ordasi

  • Tamas Jordan

  • Laszlo Molnar

  • John McDermott

  • Vanessa Zann

  • Ann Church

  • Stuart Mair

  • Genoveva Filipcsei

  • Gabor Heltovics

Medical Centers

  • NanGenex Inc., 1038 Budapest, Hungary

  • Quotient Sciences Ltd, Nottingham, United Kingdom

  • Druggability Techologies Holdings Ltd., Swatar, Malta

Locations

  • United Kingdom

  • Malta

  • Hungary

Companies

  • NanGenex Inc.

  • Quotient Sciences Li

  • Druggability Technol

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Zytiga

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved